Open navigation
Search
Search

Select your region

Life Sciences & Healthcare

Latest

  • Support for EU-wide PFAS restriction with targeted derogations: what happens next?
    08 Apr 2026 4 min read
  • Transposition Time Updates – Nordic Trio: Denmark, Finland, and Sweden Progress Towards New EU Product Liability Directive Implementation
    12 Feb 2026 6 min read

We work with and have established long-term relationships with the top 100 lifesciences companies in the areas of pharmaceuticals, medical devices, biotechnology, agriculture and food, including the top 20 global pharmaceutical companies and nine out of the top ten global medical device companies. Our lifesciences teams in Turkiye and the wider region advise leading global business groups in the sector on transactions, commercial agreements, compliance, investigations and litigation, very often across multiple jurisdictions in the region and beyond. We can help you to navigate the regulatory landscape and to ensure compliance with both local laws and global policies.

With over 480 international specialist lawyers across CMS and the support of the Lifesciences Asia-Pacific Network (LAN), we understand the scientific and commercial as well as the legal imperatives affecting your lifesciences business. Our experts, many of whom have worked in-house in your sector, have developed a shared capability in the areas of pharmaceuticals, biotechnology, medical devices and diagnostics. With active memberships in major industry associations such as the ABPI, ABHI, BIVDA, PAGB, EUCOMED and EFPIA, we help shape the legal frameworks impacting the lifesciences sector. We regularly advise our clients on their day-to-day operational needs such as support with advertisement and promotion of medicine, public sector procurement, pricing and reimbursement, patent enforcement, commercial and clinical trial agreements as well as regulatory advice.

Life Sciences & Healthcare Insights

CMS Expert Guide to advertising of medicines and medical devices

13 Apr 2026 2 min read

Support for EU-wide PFAS restriction with targeted derogations: what happens next?

08 Apr 2026 4 min read

Transposition Time Updates – Nordic Trio: Denmark, Finland, and Sweden Progress Towards New EU Product Liability Directive Implementation

12 Feb 2026 6 min read

Positive and negative pointers in clinical trial prior art: diverging inventive step outcomes at the EPO and UPC

08 Jan 2026 13 min read

Türkiye updates personal health data rules to align with law and access controls

15 Dec 2025 3 min read

Digital health apps and telemedicine: Updated CMS Expert Guide for 30 jurisdictions

01 Dec 2025 2 min read

CMS Expert Guide to digital health apps and telemedicine

12 Nov 2025 2 min read

A phase III clinical trial protocol does not by itself provide a reasonable expectation of success of the investigated treatment (T 122/23)

20 Aug 2025 15 min read

Events

  • Turkiye
    21 Apr 2026

    On the Pulse webinar series 2026 - Spring/Summer

  • Turkiye
    28 Apr 2026

    IP Insights webinar series 2026

  • Turkiye
    02 May 2026

    CMS at INTA 2026

  • Turkiye
    05 May 2026

    Joint seminar with CMS and Tannenbaum Helpern - A global perspective on securing, maintaining, and enforcing...

  • Turkiye
    28 May 2026

    CMS International Crypto Forum 2026

Local market knowledge. Global outlook

We provide future-facing legal advice to help your organisation thrive. Combining local market knowledge and a global perspective, and with lawyers in locations worldwide, your organisation benefits from the expertise it needs, even across borders.

About CMS
People across CMS Find a Lawyer
10,000+ Staff
7,200+ Lawyers
Locations across CMS Find an office
50+ Countries
90+ Offices
22 Member firms
Back to top Back to top